Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Research groups

Faheem Seedat

MBBCh, MMed, MRCP, FCP(SA), Cert Endocrinology and Metabolism (SA)


DPhil student, Endocrinologist

  • PI Group: Prof Manu Vatish, NDWRH
  • PI Group: Prof John Todd, Diabetes and Inflammation Laboratory, Centre for Human Genetics

Molecular Characterisation of the Placental-Islet Axis

BIOGRAPHY

I am a clinical endocrinologist, having trained and practised in the South African healthcare sector. I completed my undergraduate medical degree at the University of the Witwatersrand, followed by specialist training in Internal Medicine and sub-specialist training in Endocrinology, Diabetes, and Metabolism.

My Master’s in Medicine, also from the University of the Witwatersrand, investigated the effects of the widely used antiretroviral drug tenofovir on acute kidney injury in hospitalised HIV-positive patients, examining its impact on disease severity and clinical outcomes.

Currently based at the Nuffield Department of Women's and Reproductive Health at the John Radcliffe Hospital and the Centre for Human Genetics, my DPhil research at the University of Oxford focuses on the molecular signalling pathways between the placenta and pancreatic islets. Specifically, I am investigating how placental hormones and extracellular vesicles (pEVs) influence maternal islet adaptation during pregnancy, both in physiological states and in gestational diabetes mellitus (GDM). My work also involves studying protein abundance in human islets from pregnant donors, with a particular emphasis on pregnancy-induced alterations in alpha and beta cells, as well as the expression and roles of prolactin receptors, the 5-HT₂B (serotonin) receptor, and glucagon-like peptide-1 (GLP-1). This research aims to advance our understanding of placental contributions to maternal metabolic adaptations and the pathophysiology of GDM.

AWARDS

2023 EYES Research Observership Programme, European Society of Endocrinology 

Recent publications

More publications